Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brand-name vs Generic Latanoprost in Glaucoma/OHT
NCT02047630Phase 4Terminated
- Sponsor
- CHU de Québec-Université Laval
- Start
- Jan 2014
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of latanoprost in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by CHU de Québec-Université Laval. Started Jan 2014; status: terminated.
02
Drugs
latanoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT02047630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047630.